Back
Jeroen Tas
Cofounder, Mphasis

#13 João Bocas interviews Jeroen Tas, talking Innovation, Business Models & Personalised Health

🎥 Apr 07, 2021 📺 HealthcareUncomplicatedbyJooBocas ⏱ 16m
João Bocas - The Wearables Expert ™ interviews Jeroen Tas - Chief Innovation & Strategy Officer at Philips. In this episode, we talked about the #Innovation in Healthcare, Business Models in Care and Personalised #Health. #JeroenTas also talked about Health Systems, the need for Innovation, and better healthcare reorganization, wherein his words "We have to almost flip it 180 degrees". Share this episode with your networks -    • #13 João Bocas interviews Jeroen Tas,...   Connect with Jeroen Tas: LinkedIn -   / jeroentas   Twitter -   / jeroentas   Feel free to 📣 CONNECT WITH ME 🟢: Li...
Watch on YouTube

About Jeroen Tas

Jeroen Tas, a cofounder of Mphasis and former Chief Innovation & Strategy Officer at Philips, has discussed the need for healthcare systems to shift from a focus on sick care to personalized, preventive health. In a 2021 interview, Tas stated that healthcare must be "flipped 180 degrees" and described a future where individuals carry their own data and receive care tailored to them. He noted that achieving this shift faces barriers such as existing reimbursement models and vested interests, but pointed to examples like retailers entering healthcare and systems combining payer and provider roles as drivers of change. Tas has emphasized the role of digital platforms and wearables in enabling early detection and personalized care. He cited Philips' HealthSuite digital platform as a tool to aggregate data from multiple sources to create patient profiles and improve care. Tas also highlighted the potential for digital channels to democratize access to high-quality care, suggesting that a small hospital in a developing region could provide world-class diagnosis and treatment for complex diseases like cancer. He has described this as part of a "new era" where people are empowered to manage their health with support from a care network.

Source: AI-verified profile updated from Jeroen Tas's recent appearances. Browse all interviews →

Transcript (13 segments)
H
Host0:16
Hello and welcome to another fantastic episode of the Digital Health and Wearables series. Before I go ahead, I would like to acknowledge our global partners and sponsored Spirit Digital. Please check them out in a link in the description below. Also, many thanks to our viewers and listeners, also now on the podcasts. Feel free to subscribe here on YouTube, but now we are also on podcasts on Spotify, Apple, and Google, so more ways for you to follow our amazing content. I'm truly excited today, without further ado, to introduce Jeroen Tas, which is a pleasure to see you. I think the first memory that I have of you, we met very briefly in HLTH Week 2016 when you were doing a big presentation, the things that you do best around the Philips stand, and it was very, very busy. I don't know if you remember that.
J
Jeroen Tas1:33
Yeah, I remember that. Good seeing you again, albeit virtual.
H
Host1:40
Nice to see you again. We both follow healthcare, your great work generally. By the way, the first question that I have for you is: what do you think is the hardest part in healthcare innovation?
J
Jeroen Tas1:55
That's a very good question. The reason we expect to live much longer than our parents is because of tremendous innovation in diagnostics, from blood tests to imaging to pathology. We've seen tremendous innovation in therapies, heart procedures, and recently new types of therapies like immunotherapies. But if you look at the innovation of the healthcare system as a system, it has been very slow. In the Western world, most systems haven't really substantially changed since they were founded after World War Two. The next wave of innovation will be the way healthcare is organized. That means we have to flip it 180 degrees because right now healthcare is organized around providers. If you have a problem, your GP will refer you to specialists, the specialist will do diagnosis, put you on therapy, and there may be a little bit of care afterwards, but it's on the terms of the providers. The big shift is going to be about you. You're going to carry your data, you're going to be referred to the right provider, and it's going to be very, very personalized. So the next wave of innovation is going to be truly personalized. Who are we to come around and say, 'Hey, you got to change the way you work?'
H
Host4:10
Fantastic. So much that you describe there, many things to consider, certainly the barriers, the systems, the innovation turning upside down. The second question that I have for you is: Philips traditionally was a lighting company. What do you think are the main challenges as a brand and your brand positioning to be seen as a leader in healthcare technology?
J
Jeroen Tas4:42
I think that's an excellent question. Obviously, we're a 130-year-old company, and you cannot stop people from having associations with that brand that may date back 20 years. For its technology, no, we're going to turn that around. We're going to be a health tech company whose purpose in life is to positively touch the lives and improve the health of billions of people. Actually, we're looking at two billion people by 2025. Now, you're completely changing your purpose, the reason of being, and you need to organize around that and change your portfolio. So we decided to divest lighting, consumer electronics, and now domestic appliances so that we can really focus on that purpose. Along the way, I think we need to prove to the world that we're truly helping them live healthier lives. More tuned therapy, so we want to march towards that world where healthcare is truly personal, where the diagnosis is truly precise, and where care is tailored to you. We have to bring the audience along on that journey and say, 'Hey, we're no longer a lighting company, we're no longer consumer electronics. We're here to help you live healthier lives.'
H
Host6:40
Oh fantastic. I really love the mission, a fantastic ambitious mission to touch the lives of two billion people. You have been doing great work the last few years, and I've been following you for quite some time. The third and last question I have for you is: what is the role of the patient or consumer in healthcare delivery of the future?
J
Jeroen Tas7:19
Well, I think that's a very good question because it comes back to what I said earlier. If healthcare becomes truly personalized and it's about you and your own understanding of your health and the goals you set yourself for health, then it means that you have to get involved. In other words, you have to be conscious about what drives your health, and you have to be properly helped, or if you can do it yourself, drive towards better outcomes. In order to do that, we need to help you get a much better picture of yourself. For example, I have a genetic predisposition for a certain disease that runs in the family, and I got it when I was born. Now I know it, I also need to understand how I can control it. My daughter has type 1 diabetes; she couldn't help it, it's not a lifestyle choice, it's something that happened and changed her life. So once we know what our risks are, once we know what our drivers are, which can be very personal, and you can do that by doing genetic tests, a heart test, or by understanding how you eat, how you sleep, whether you have stress, your social life, your education on health, all of these determine how you live your life, whether you can live a fulfilling healthy life. I believe these other factors play an equally important role. So when it comes to your own personal health, there's a lot of education, guidance, and insights, but ultimately you make the choice for yourself whether you want to do something about it. We've also seen models where the family gets involved. For instance, my daughter is 30 years old, living independently, but still my wife and I are very much involved in making sure she lives as healthy a life as possible. So I believe that many people also have support systems. Wearables play a big role in that. People say maybe a Fitbit is not fully clinically relevant, but you don't need full clinical relevance to understand patterns. Once you understand patterns, you can help change those patterns if they can lead to positive outcomes. So there's a whole lot to do there. I also see business models will change to support that. You already see many healthcare systems in the US where they combine the payer and provider role. If you're a payer provider, you have a big incentive to keep people healthy because if people are unhealthy, you have huge downstream costs. You see employers getting very conscious of the need for change. So employers, combination payer providers, and now big retailers getting into the game as well. You're in the UK, and I know that Walgreens Boots is really looking at creating a more healthy retail experience and linking that to care. We see Walmart getting in the game, CVS acquired Aetna. So if a big retailer buys a health insurer, the goal is going to be helping people live healthier lives and avoid expensive downstream care if that's feasible. So I think their role is to reduce stress, sleep better, all in support of a healthier life and controlling chronic disease.
H
Host12:22
Brilliant. There was a fantastic insight. You mentioned so much in that, a bigger picture of personalized health. You mentioned not just about the diagnostics, you mentioned the change of behavior, many factors. A fantastic answer. Thank you so much. We could talk for hours, as you know. Each question is interesting, and your expertise and knowledge, we could talk for a long time, but we finished the episode. I finished all my episodes. This is a bit of a surprise for you in the same way, which is a one minute of fame.
J
Jeroen Tas13:11
Well, I'm at the moment working with David Agus, who is quite a famous doctor and a great oncologist but also a visionary on health. I'm working very closely with him to see how we can not only avoid people getting sick but also how to care much better for people when they're sick, have a much more precise diagnosis, specifically in the space of cancer care. Having the right tests after somebody has been treated for cancer, making sure you stay in touch and stop the disease as early as possible, but do it in a way that all the knowledge we build up there will become available to the entire world. I know that specialized cancer care is really the domain of super specialists with the complexity of the therapies, so it will be impossible for community hospitals to always be up to date and provide world-class cancer care unless you create a digital channel where you bring that expertise from David Agus or from Dana-Farber, which we're working on, and really make that knowledge available to the world. So democratizing very high quality care through digital channels means that a doctor in a small town in India or Brazil can actually provide world-class diagnosis and treatment of complex diseases like cancer. That makes me truly excited.
H
Host15:23
Well fantastic, Jeroen. What a way to finish the episode with something that really will cause a big impact in a major way. I would like to personally thank you for your time. I know you are busy, and thank you so much for doing the episode with us. Nice to see you.
J
Jeroen Tas15:41
It was my pleasure. Always good to see you. Keep spreading the good news with your series.
H
Host15:50
Thank you so much. I'm going to finalize by thanking the viewers and the listeners. Make sure you subscribe.